Wegovy 1.5 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV2Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,235
Award facts
- Contract value 100% obligated
- $20,235.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,235.30 to AmerisourceBergen Drug Corp for Wegovy 1.5 mg tablets (30-count units) on January 23, 2026, with an ultimate completion date of January 26, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of medications and medical commodities to federal agencies, particularly the Department of Defense and veterans' healthcare systems. This delivery order for Wegovy, a diabetes and weight management medication, reflects the contractor's established role in fulfilling specialized pharmaceutical procurement requirements for military and defense healthcare operations. As a competitively awarded vendor under the DLA Troop Support Medical IDC, AmerisourceBergen has demonstrated consistent capability to meet federal medical supply needs through a diversified portfolio of brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQV2Q?
SPE2DR26FQV2Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FQV2Q worth?
The government has obligated $20,235 on SPE2DR26FQV2Q.
Is contract SPE2DR26FQV2Q an order under another contract?
Yes. SPE2DR26FQV2Q is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV2Q competed?
The extent of competition for SPE2DR26FQV2Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award